Consistent with these observations, deficient glucosylceramidase can lead to the formation of α-synuclein aggregates, which are a main component of Lewy bodies that are present in Gaucher patients that develop Parkinson’s disease or Lewy body dementia [105,111,112,113]. Here, GBA1 is linked to Parkinson disease.